<DOC>
	<DOCNO>NCT00092612</DOCNO>
	<brief_summary>The purpose study investigate additional cholesterol lower effect patient coronary heart disease give investigational drug patient 's current approve cholesterol lower medication .</brief_summary>
	<brief_title>Co-administration Study Patients With Elevated Cholesterol Coronary Heart Disease ( 0653-802 ) ( COMPLETED )</brief_title>
	<detailed_description>The duration treatment 10 week .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Patients elevate cholesterol coronary heart disease Patients cholesterol level within normal range identify study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Elevated Cholesterol</keyword>
</DOC>